A Thermoresponsive Bubble-Generating Liposomal System for Triggering Localized Extracellular Drug Delivery
Source abstract
Abstract
The therapeutic effectiveness of chemotherapy is optimal only when tumor cells are subjected to a maximum drug exposure. To increase the intratumoral drug concentration and thus the efficacy of chemotherapy, a thermoresponsive bubble-generating liposomal system is proposed for triggering localized extracellular drug delivery. The key component of this liposomal formulation is the encapsulated ammonium bicarbonate (ABC), which is used to create the transmembrane gradient needed for a highly efficient encapsulation of doxorubicin (DOX). At an elevated temperature (42 °C), decomposition of ABC generates CO(2) bubbles, creating permeable defects in the lipid bilayer that rapidly release DOX and instantly increase the drug concentration locally. Because the generated CO(2) bubbles are hyperechogenic, they also enhance ultrasound imaging. Consequently, this new liposomal system encapsulated with ABC may also provide an ability to monitor a temperature-controlled drug delivery process.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Ultrasound and Hyperthermia Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering and Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan, ROC
Biomedical Technology and Device Research Laboratories, Industrial Technology Research Institute, Hsinchu 30013, Taiwan, ROC
The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332, United States
Department of Electrical Engineering, Chang-Gung University, Taoyuan 33302, Taiwan, ROC
References (33)
Show source-provided references
1. Barenholz Y. · J. Controlled Release · 2012 · 160 · 11710.1016/j.jconrel.2012.03.020 ↗
2. Yang F. · Cancer Treat. Rev. · 2011 · 37 · 63310.1016/j.ctrv.2011.01.006 ↗
3. Elbayoumi T. A. · Clin. Cancer Res. · 2009 · 15 · 197310.1158/1078-0432.CCR-08-2392 ↗
4. Pornpattananangkul D. · ACS Nano · 2010 · 4 · 193510.1021/nn9018587 ↗
5. Tagami T. · J. Controlled Release · 2011 · 154 · 29010.1016/j.jconrel.2011.05.020 ↗
6. Allen T. M. · Science · 2004 · 303 · 181810.1126/science.1095833 ↗
7. Chang H. I. · Int. J. Nanomed. · 2012 · 7 · 49
8. Dromi S. · Clin. Cancer Res. · 2007 · 13 · 272210.1158/1078-0432.CCR-06-2443 ↗
9. Shenoi M. M. · Nanomedicine · 2011 · 6 · 54510.2217/nnm.10.153 ↗
10. Chiu G. N. · J. Controlled Release · 2005 · 104 · 27110.1016/j.jconrel.2005.02.009 ↗
11. Banno B. · Pharm. Sci. · 2010 · 99 · 229510.1002/jps.21988 ↗
12. Cullis P. R. · Adv. Drug Delivery Rev. · 1998 · 32 · 310.1016/S0169-409X(97)00128-2 ↗
13. Mills J. K. · Biochim. Biophys. Acta · 2005 · 1716 · 7710.1016/j.bbamem.2005.08.007 ↗
14. Min B. · Bioresour. Technol. · 2010 · 101 · 541410.1016/j.biortech.2010.02.022 ↗
15. Chung M. F. · Angew. Chem., Int. Ed. · 2012 · 51 · 1008910.1002/anie.201205482 ↗
16. Cern A. · J. Controlled Release · 2012 · 160 · 14710.1016/j.jconrel.2011.11.029 ↗
17. Tagami T. · J. Controlled Release · 2012 · 161 · 14210.1016/j.jconrel.2012.03.023 ↗
18. Bolotin E. M. · J. Liposome Res. · 1994 · 4 · 45510.3109/08982109409037057 ↗
19. Cern A. · J. Controlled Release · 2012 · 160 · 14710.1016/j.jconrel.2011.11.029 ↗
20. Boddien A. · Angew. Chem., Int. Ed. · 2011 · 50 · 641110.1002/anie.201101995 ↗
21. Yang Y. · Biomaterials · 2009 · 30 · 194710.1016/j.biomaterials.2008.12.044 ↗
22. Eisenbrey J. R. · J. Controlled Release · 2010 · 143 · 3810.1016/j.jconrel.2009.12.021 ↗
23. Riehemann K. · Angew. Chem., Int. Ed. · 2009 · 48 · 87210.1002/anie.200802585 ↗
24. Soussan E. · Angew. Chem., Int. Ed. · 2009 · 48 · 27410.1002/anie.200802453 ↗
25. Boyer C. · ACS Nano · 2007 · 1 · 17610.1021/nn7002025 ↗
26. Allen T. M. · Nat. Rev. Cancer · 2002 · 2 · 75010.1038/nrc903 ↗
27. Nowak P. · Chem. Eng. Sci. · 1989 · 44 · 237510.1016/0009-2509(89)85170-X ↗
28. Ke C. J. · Angew. Chem., Int. Ed. · 2011 · 50 · 808610.1002/anie.201102852 ↗
29. Kang E. · Angew. Chem., Int. Ed. · 2010 · 49 · 52410.1002/anie.200903841 ↗
30. Yamada A. · Clin. Cancer Res. · 2008 · 14 · 816110.1158/1078-0432.CCR-08-0159 ↗
31. Gary D. J. · ACS Nano · 2011 · 5 · 349310.1021/nn102540y ↗
32. McNeeley K. M. · Biomaterials · 2009 · 30 · 398610.1016/j.biomaterials.2009.04.012 ↗
33. Riganti C. · Cancer Res. · 2005 · 65 · 51610.1158/0008-5472.516.65.2 ↗